Innovata backs out of SkyePharma bid
Innovata has backed out of discussions for the possible "all-share" takeover of beleaguered drug development company SkyePharma, citing its inability to be competitive with cash-based offers from other companies.
Innovata has backed out of discussions for the possible "all-share" takeover of beleaguered drug development company SkyePharma, citing its inability to be competitive with cash-based offers from other companies.
As worldwide fears of a bird flu pandemic escalates, US border control are fighting an influx of fake Tamiflu products being imported into the country. Such products have been surfacing across the country as the global Tamiflu shortage has led to a...
Bayer has acquired Icon Genetics in a culmination of an existing agreement between the two companies. The deal also solidifies Bayer's direction as it soughts to strengthen its efforts to produce specific plant-made pharmaceuticals.
Canadian biotech company Generex has begun a study of its flagship oral insulin spray in patients with Type-1 diabetes. The product, already available for type 2 diabetes in Ecuador, was the first non-injectable form of insulin to reach the market...
Maxxon are to receive delivery of the first 5,000 batch of its functional 3 cc Vacuum Operated Retractable Safety Syringe ("ReVac"), which is set to spark a price war amongst fellow manufacturers in the Safety-engineered medical devices (SEMDs) arena.